Peptide Synthesis Quality Control
How quality is maintained throughout the peptide synthesis process — from resin to purified product.
Scientific background / literature overview only. Discussion of published research does not describe the intended use of Novex Peptide products.
Introduction
Quality control in peptide synthesis is a multi-stage process that begins with raw material selection and ends with the final analytical verification of the purified peptide. Each step has specific quality checkpoints.
Raw Material Quality
Amino Acid Building Blocks
Fmoc- or Boc-protected amino acids must meet purity specifications (typically ≥99%). Impurities in the building blocks lead to deletion sequences and other impurities in the final product.
Resin Quality
The solid support resin must have consistent loading capacity and particle size. Variations in resin quality can affect coupling efficiency.
Solvents and Reagents
Synthesis-grade solvents (DMF, NMP, DCM) must be of high purity to avoid side reactions. Reagents used for coupling and deprotection must be fresh and properly stored.
In-Process Monitoring
Coupling Efficiency
Each amino acid coupling step should go to near-completion (>99.5%). Incomplete coupling results in deletion sequences — truncated peptides missing one or more residues.
Capping
After each coupling step, unreacted amino groups are "capped" (acetylated) to prevent them from participating in subsequent couplings. This converts potential deletion sequences into shorter, more easily removed impurities.
Kaiser Test
The ninhydrin (Kaiser) test is used to monitor coupling completeness. A negative Kaiser test indicates complete coupling; a positive test indicates unreacted amino groups.
Post-Synthesis Processing
Cleavage
The peptide is cleaved from the resin using acid (TFA for Fmoc strategy, HF for Boc strategy). Cleavage conditions must be optimised to avoid side reactions.
Precipitation and Washing
The cleaved peptide is precipitated in cold ether and washed to remove small-molecule impurities and protecting group remnants.
Purification
Reverse-phase HPLC is the standard purification method. The crude peptide is separated into fractions, and the fraction containing the target peptide at the required purity is collected.
Final Quality Verification
Analytical HPLC
A sample of the purified peptide is analysed by analytical RP-HPLC to confirm purity. The chromatogram should show a single dominant peak at the expected retention time.
Mass Spectrometry
The molecular weight is confirmed by mass spectrometry (MALDI-TOF or ESI-MS). The measured mass must match the theoretical mass.
Certificate of Analysis
All quality data is compiled into a COA, which accompanies every batch of peptide supplied for research use.
Research Limitations
Quality control processes ensure chemical quality but do not confirm biological activity. All products are supplied for research use only.
References
- 1.Merrifield RB. Solid Phase Peptide Synthesis. J Am Chem Soc. 1963;85(14):2149-2154.
- 2.Atherton E, Sheppard RC. Solid Phase Peptide Synthesis. IRL Press; 1989.
- 3.Wellings DA, Atherton E. Standard Fmoc Protocols. Methods Enzymol. 1997;289:44-67.
Research use only. This article is for educational purposes only and does not constitute advice for any application involving human use. No medical claims are made.
